Logo image
Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)
Journal article   Peer reviewed

Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)

Courtney Waugh, Ray Austin, Adam Polkinghorne and Peter Timms
Biologicals, Vol.44(6), pp.588-590
2016
url
https://doi.org/10.1016/j.biologicals.2016.09.006View
Published Version

Abstract

vaccine koala chlamydia pecorum therapeutic vaccine major outer membrane protein
Koalas (Phascolarctos cinereus) are affected by debilitating chlamydial disease that can lead to blindness, infertility, and death. The causative agent is the intracellular bacterium Chlamydia pecorum. While antibiotics can be used to treat koala chlamydial infection, they are often ineffective or cause severe dysbiosis to the animal's unique gut flora. Recent work has progressed on the development of a protective vaccine for Chlamydia in the koala. This study demonstrates that the use of a vaccine can have a positive effect in koalas already with clinical signs of ocular disease, suggesting a possible therapeutic effect and an alternative to antibiotic therapy.

Details

Metrics

6 File views/ downloads
556 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Web Of Science research areas
Biochemical Research Methods
Biotechnology & Applied Microbiology
Pharmacology & Pharmacy

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image